DRI Healthcare Trust acquires royalty stake in Sebetralstat sales

DRI Healthcare Trust is also making a $5 million investment in KalVista, a biopharmaceutical company based in Cambridge, Massachusetts.

5 November 2024•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.